Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.50 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.50 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.50 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.50 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.50 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3757586 | 0.83 | NPC1 (0.52) | MEN1KMT2ANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5656197 | 0.82 | APOBEC3A (0.55) | MEN1KMT2ANPC1RAB9A | |
| SCHEMBL5188030 | 0.78 | KMT2A (0.51) | MEN1KMT2AATMPSEN1PSEN2 | |
| SCHEMBL14427596 | 0.78 | MEN1 (0.67) | MEN1KMT2AATMPSEN1PSEN2 | |
| SCHEMBL1701279 | 0.77 | KMT2A (0.76) | MEN1KMT2AATMPSEN1PSEN2 | |
| SCHEMBL7772334 | 0.74 | KMT2A (0.71) | MEN1KMT2AATMPSEN1PSEN2 | |
| SCHEMBL7972682 | 0.73 | KMT2A (0.69) | MEN1KMT2AATMPSEN1PSEN2 | |
| Carbamic Acid SCHEMBL7116890 | 0.73 | KMT2A (0.69) | MEN1KMT2AATMPSEN1PSEN2 | |
| SCHEMBL14442982 | 0.73 | KMT2A (0.69) | MEN1KMT2AATMPSEN1PSEN2 | |
| SCHEMBL13167408 | 0.73 | KMT2A (0.69) | MEN1KMT2AATMPSEN1PSEN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7842812-B2 | Substituted 5-aminomethy1-1H-pyrrole-2-carboxylic acid amides | GRUENENTHAL GMBH (DE) | 2010-11-30 | — | — | US | disclosed |
| US-20070135494-A1 | Substituted 5-aminomethyl-1H-pyrrole-2-carboxylic acid amides | GRUENENTHAL GMBH (DE) | 2007-06-14 | — | — | US | disclosed |
| US-7229991-B2 | Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides | GRUENENTHAL GMBH (DE) | 2007-06-12 | — | — | US | disclosed |
| US-20050288342-A1 | Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides | GRUENENTHAL GMBH (DE) | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135494-A1 | Substituted 5-aminomethyl-1H-pyrrole-2-carboxylic acid amides | AVPR2, GPR119, AVPR1B | MEN1 2122/4885KMT2A 1381/4885ATM 2010/4885 |
| US-20050288342-A1 | Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides | QPCT, PGA5, ALDH18A1 | MEN1 2422/4885KMT2A 1319/4885ATM 3817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.